QIAGEN N.V. (QGEN) Forecast, Price Target & Analyst Ratings

NYSE:QGENNL0015002SN0

Current stock price

39.93 USD
-0.72 (-1.77%)
At close:
39.93 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QIAGEN N.V. (QGEN).

Forecast Snapshot

Consensus Price Target

Price Target
$55.35
+ 38.62% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.56
Revenue Estimate
511.3M

ChartMill Buy Consensus

Rating
71.67%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$55.35
Upside
+ 38.62%
From current price of $39.93 to mean target of $55.35, Based on 24 analyst forecasts
Low
$50.50
Median
$54.44
High
$64.05

Price Target Revisions

1 Month
1.17%
3 Months
7.13%

Price Target Summary

24 Wall Street analysts provided a forecast for the next 12 months for QGEN. The average price target is 55.35 USD. This implies a price increase of 38.62% is expected in the next year compared to the current price of 39.93.
The average price target has been revised upward by 7.13% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

QGEN Current Analyst RatingQGEN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

QGEN Historical Analyst RatingsQGEN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
71.67%
QGEN was analyzed by 24 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about QGEN.
In the previous month the buy percentage consensus was at a similar level.
QGEN was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-13Deutsche BankUpgrade Hold -> Buy
2026-02-06StifelMaintains Hold -> Hold
2026-02-06JP MorganMaintains Overweight -> Overweight
2026-02-06CitigroupMaintains Neutral -> Neutral
2026-01-22Deutsche BankDowngrade Buy -> Hold
2025-12-15BarclaysMaintains Overweight -> Overweight
2025-12-11CitigroupDowngrade Buy -> Neutral
2025-10-02BarclaysMaintains Overweight -> Overweight
2025-08-07UBSMaintains Neutral -> Neutral
2025-06-26B of A SecuritiesMaintains Buy -> Buy
2025-06-24BarclaysInitiate Overweight
2025-04-21BairdMaintains Neutral -> Neutral
2025-04-04Redburn AtlanticDowngrade Buy -> Neutral
2025-02-19BairdDowngrade Outperform -> Neutral
2025-02-07UBSMaintains Neutral -> Neutral
2025-01-06Morgan StanleyDowngrade Overweight -> Equal-Weight
2024-10-17HSBCDowngrade Buy -> Hold
2024-08-02BairdMaintains Outperform -> Outperform
2024-06-27Wolfe ResearchUpgrade Peer Perform -> Outperform
2024-06-18JP MorganMaintains Overweight -> Overweight
2024-05-01StifelMaintains Hold -> Hold
2024-02-16Morgan StanleyUpgrade Equal-Weight -> Overweight
2024-02-08JP MorganMaintains Overweight -> Overweight
2024-02-08CitigroupMaintains Buy -> Buy
2023-12-20JP MorganMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.56
Revenue Estimate
511.3M
Revenue Q2Q
5.76%
EPS Q2Q
-3.98%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-1.57%
Revenue (3 Months)
-1.73%
EPS (1 Month)
-3.35%
EPS (3 Months)
-5.36%

Next Earnings Summary

QGEN is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.56 USD and the consensus revenue estimate is 511.30M USD.
The next earnings revenue estimate has been revised downward by 1.73% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
QGEN revenue by date.QGEN revenue by date.
1.965B
-8.23%
1.978B
0.66%
2.09B
5.65%
2.261B
8.18%
2.389B
5.66%
2.534B
6.07%
2.826B
11.52%
3.077B
8.88%
EBITDA
YoY % growth
QGEN ebitda by date.QGEN ebitda by date.
650.583M
-17.08%
698.225M
7.32%
714.056M
2.27%
836.69M
17.17%
903.3M
7.96%
977.45M
8.21%
1.007B
3.02%
1.05B
4.27%
EBIT
YoY % growth
QGEN ebit by date.QGEN ebit by date.
445.247M
-22.73%
494.957M
11.16%
520.31M
5.12%
642.32M
23.45%
697.22M
8.55%
763.5M
9.51%
906.98M
18.79%
994.81M
9.68%
Operating Margin
QGEN operating margin by date.QGEN operating margin by date.
22.66%25.02%24.90%28.41%29.18%30.13%32.09%32.33%
EPS
YoY % growth
QGEN eps by date.QGEN eps by date.
2.18
-13.35%
2.24
2.65%
2.47
10.63%
2.60
5.20%
2.86
10.09%
3.15
9.86%
3.41
8.29%
3.51
3.14%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.56
-3.98%
0.65
2.62%
0.66
3.39%
0.66
6.18%
0.66
19.27%
0.74
14.88%
0.71
7.55%
0.70
6.91%
Revenue
Q2Q % growth
511.3M
5.76%
565.23M
5.94%
570.78M
7.17%
573.99M
6.21%
553.46M
8.25%
594.54M
5.19%
593.32M
3.95%
594.57M
3.59%
EBITDA
Q2Q % growth
179.33M
3.85%
205.17M
-14.01%
208.68M
-26.89%
204.87M
-35.09%
213.76M
19.20%
233.84M
13.97%
228.98M
9.73%
229.65M
12.10%
EBIT
Q2Q % growth
142.88M
10.95%
166.69M
14.79%
168.55M
19.48%
169.11M
38.75%
166.55M
16.57%
189.79M
13.86%
180.03M
6.81%
176.58M
4.42%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

QGEN Yearly Revenue VS EstimatesQGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QGEN Yearly EPS VS EstimatesQGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.36%
EPS Next 5 Year
7.28%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.14%
Revenue Next 5 Year
7.75%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
17.72%
EBIT Next 5 Year
11.87%

QIAGEN N.V. / QGEN Forecast FAQ

What do analysts expect the price target to be for QIAGEN N.V. (QGEN)?

24 analysts have analysed QGEN and the average price target is 55.35 USD. This implies a price increase of 38.62% is expected in the next year compared to the current price of 39.93.

Can you provide the upcoming earnings date for QIAGEN N.V.?

QIAGEN N.V. (QGEN) will report earnings on 2026-05-05, after the market close.

What are the consensus estimates for QGEN stock next earnings?

The consensus EPS estimate for the next earnings of QIAGEN N.V. (QGEN) is 0.56 USD and the consensus revenue estimate is 511.30M USD.

Can you provide the expected long term growth rate for QIAGEN N.V. stock?

The expected long term growth rate for QIAGEN N.V. (QGEN) is 6.14%.